Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells

SIMPLE SUMMARY: Estrogen receptor α (ERα) is a key driver and clinical target in breast cancer, with ~75% of women having ERα+ breast tumors at diagnosis. Endocrine therapies (tamoxifen and aromatase inhibitors) targeting ERα are the preferred treatment for ER+/HER2− breast tumors due to their effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Muluhngwi, Penn, Klinge, Carolyn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307416/
https://www.ncbi.nlm.nih.gov/pubmed/34298743
http://dx.doi.org/10.3390/cancers13143530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307416/
https://www.ncbi.nlm.nih.gov/pubmed/34298743
http://dx.doi.org/10.3390/cancers13143530

Ejemplares similares